2026年
原著論文
-
"Plasma coproporphyrins for evaluating OATP1B and OATP2B1 activities: Coproporphyrin-III unsuitable as an OATP2B1 biomarker in Japanese general population"
Negami J, Suzuki Y, Koyama T, Yamazaki M, Oda A,Ozaki E, Yamamoto Y, Nakatochi M, Momozawa Y, Takashima N, Matsuo K, Ohno K
Drug Metabolism and Disposition 54, 100276 (2026).
-
"Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics"
Negami J, Suzuki Y, Koyama T, Oda A, Iino K, Suzuki S, Yamagishi N, Kamio N, Ozaki E, Yamamoto Y, Nakatochi M, Momozawa Y, Tanaka R, Ono H, Sumimoto T, Tatsuta R, Itoh H, Takashima N, Matsuo K, Ohno K
Drug Metabolism and Disposition 54, 100366 (2026).
-
"Search for novel biomarkers to predict cytochrome P450 2C19 activity using untargeted metabolomics of human plasma"
Oda A, Suzuki Y, Koyama T, Negami J, Suzuki S, Iino K, Yamagishi N, Kamio N, Ozaki E, Yamamoto Y, Nakatochi M, Momozawa Y, Tanaka R, Ono H, Sumimoto T, Tatsuta R, Itoh H, Takashima N, Matsuo K, Ohno K
Metabolites 16, 670 (2026).
国内学会（一般講演・ポスター発表）
国際学会（一般講演・ポスター発表）
-
-
"Discovery of novel CYP3A5 biomarker candidates by non-targeted metabolomics in Japanese general population and patients cohorts"
Yamagishi N, Suzuki Y, Oda A, Negami J, Iino K, Suzuki S, Kamio N, Koyama T, Ozaki E, Tanaka R, Ono H, Sumimoto T, Tatsuta R, Itoh H, Takashima N, Ohno K
IATDMCT 2026 Congress, 2026/9, France (2026).